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ABSTRACT: 
Objectives: Transdermal drug delivery suggests several advantages and has been 
vastly investigated over last decades. Chemical enhancers improve the quantity of 
drug penetration through the skin. In this study, hydrophilic solvents have been used 
as enhancers to promote dermal penetration of albumin. 
Methods: 20 different formulations containing albumin and hydrophilic solvents 
were prepared. Transdermal absorption experiments for each formulation were 
performed using a diffusion cell and a slice of chicken skin as model at 32°C for 3 
hours. Samples from the medium were withdrawn and analyzed for albumin 
concentration. Cumulative amounts of albumin were plotted for each formulation. 
Results: After 3 hours, 6.8, 5.8, 69.0, 7.9, 11.1, 25.2, 32.0, 98.0, 21.3 and 74.3 mg of 
albumin were passed through the skin, using formulations containing deionized 
water (DW), acetic acid, ethyl acetate (EA), methanol, ethanol, 2-propanol, 
isopropyl alcohol (IPA), glycerol, ethylene glycol (EG) and propylene glycol (PG), 
respectively.  
Conclusion: PG, EA and glycerol could act as enhancers for transdermal delivery of 
albumin. Such delivery was increased using 4 mL of them instead of 2 mL and using 
exposure time of 3 hours instead of 1.5 hours. The most effective enhancer was 
found glycerol, showing a maximum albumin permeation of 98.0 mg. Therefore, the 
study suggested using glycerol as enhancer for transdermal delivery of albumin or 
other similar proteins in cosmeceutical products. 
INTRODUCTION: Transdermal drug 
administration possesses many advantages 
including decreased or loss of first-pass drug 
metabolism, no gastro-intestinal degradation, long 
time delivery (especially for transdermal patches), 
controlled delivery and termination, bypassing GI 
absorption process and its dramatic pH changes, 
loss of GI enzyme effects and transit times 
1
.  
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The main barrier for transdermal drug delivery, is 
the skin’s horny layer or stratum corneum (SC). 
This layer must be altered for passage of drugs 
through the skin. This has been the subject of 
research for pharmaceutical scientists during the 
two latest decades 
2
. Extensive research on 
chemical enhancers has been performed over the 
last 20 years which form the main strategy of 
formulation-design approaches for transdermal 
drug delivery 
3
. It is now believed that formulation 
components can improve the quantity and rate of 
transdermal absorption 
4
. Permeation of a drug 
through the skin in the presence of an enhancer is 
related to physico-chemical characteristics of the 
enhancer and the drug 
5-7
.  
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More than 200 chemicals have been shown to 
enhance drugs skin permeation. Chemical 
penetration enhancers (CPEs) should build blocks 
to make new skin microstructures 
3
.  
Several enhancers have been used to enhance 
different drugs skin permeation. Such enhancers 
include aliphatic acids, fatty acids, esters, alcohols, 
oils and terpens
1
 and also variety of nanoparticle 
including elemental or polymeric nanoparticles 
7-15
. 
Albumin is a hydrophilic polypeptide with 
molecular weight of 67 kDa. It binds water, cations 
(such as Ca
2+
, Na
+
 and K
+
), fatty acids, etc. 
Albumin and other nutrient proteins have been used 
in many cosmetic products and albumin is 
sometimes used as a surfactant 
16-20
. Also we 
considered the albumin as a model protein. 
In this study, we aimed to deliver the albumin 
through the skin. Certain hydrophilic solvents were 
used to enhance the albumin transdermal 
penetration. The solvents include deionized water 
(DW), acetic acid, ethyl acetate (EA), methanol, 
ethanol, 2-propanol, isopropyl alcohol (IPA), 
glycerol, ethylene glycol (EG) and propylene 
glycol (PG). All the solvents have been widely 
used in different cosmetic products for their various 
advantages 
21
. 
Albumin skin permeation was determined using a 
diffusion cell (ex-vivo method) using a piece of 
chicken skin. The use of in vitro models is also 
supported by the fact that SC, the principle site of 
enhancer action, presents similar behavior in vivo 
and in vitro 
17
. 
MATERIALS AND METHODS: Human serum 
albumin, acetic acid, EA, methanol, ethanol, 2-
propanol, IPA, glycerol, EG and PG, all were 
purchased from Sigma-Aldrich company, USA. 
Preparation of formulations: Every formulation 
(formulations 1-20) were prepared  mixing evenly 
500 mg of albumin (as active ingredient) with 2 or 
4 mL of each solvent of table 1 and 2 (as 
enhancers), to make a lotion, using mechanical 
overhead mixer (Heidolph, RZR 2020, Germany) at 
3000 rpm for 20 minutes.  
Permeation test: The transdermal penetration of 
albumin was determined by a diffusion cell with an 
effective diffusional area of 10 cm
2
 with a glass 
cap. Its 30 mL volume receiver chamber was filled 
with DW. An isolated piece of skin of a 3 months 
old chicken was fixed between two chambers as the 
diffusional membrane, making an almost stretched 
condition of the skin. Isolated skins were carefully 
selected in order to have low underlying fat tissue. 
They were accurately selected in order to be 
completely similar in terms of thickness of fat 
tissue and the number of hair follicles. Each 
formulation (lotion) of tables 1 and 2, was placed 
and spread on the skin.  
Then the cap (donor chamber) was placed and fixed 
on that to avoid evaporation. The cell was placed in 
a shaker-incubator (Heidolph incubator 1000, 
Heidolph co., Germany) with a temperature of 
32°C for 3 hours 
3, 21
. Every 15 minutes the cap was 
taken away and the lotion was rubbed evenly by a 
swab to help the albumin penetration. 3 ml of DW 
was taken after 1.5 and 3 hours and analyzed for 
the concentration of albumin at 278 nm using a 
UV-Vs spectrophotometer (Perkin-Elmer-Lambda 
25, USA) 
22, 23
. Each time 3 ml of fresh DW was 
replaced to keep the sink condition. Cumulative 
quantities of permeated albumin (mg) were plotted 
for the related formulations. 
Statistical analysis: Each formulation was tested 3 
times for albumin permeation and the reported data 
was the mean±SD (n=3). One-way analysis of 
variance (ANOVA) was used for comparing the 
mean differences. SPSS for Windows (release 
11.5.0) was employed for statistical analysis. p-
value <0.05 was considered to be significant. 
RESULTS: The results obtained from the albumin 
permeation experiments for every formulation of 
tables 1 and 2, are presented in the same tables as 
well as in the Figures 1-10. Figures 11 and 12 are 
brought for total comparison of all the 
formulations. According to Figures 1-10, among all 
formulations (enhancers), the permeated amounts 
of albumin through the skin, were lowest for DW, 
acetic acid solution (1 M), methanol and ethanol, 
including 5.2, 5.0, 6.5 and 8.3 mg, respectively 
when 2 mL of the enhancers was used and 6.8, 5.8, 
7.9 and 11.1 mg, respectively when 4 mL of the 
enhancers was used.  
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The permeated albumin was moderate for EG, 2-
propanol and IPA, including 16.7, 19.1 and 24.0 
mg, respectively when 2 mL of the enhancers was 
used and 21.3, 25.2 and 32.0 mg, respectively when 
4 mL of the enhancers was used.  
As the third (potent) group, the permeated albumin 
was highest for EA, PG and glycerol, including 
66.0, 62.2 and 75.6 mg, respectively when 2 mL of 
the enhancers was used and 69.0, 74.3 and 98.0 mg, 
respectively when 4 mL of the enhancers was used. 
The permeated albumin for the formulations of the 
first (weakest) group were calculated as significant 
from those for the second (moderate) group 
(p<0.05).  
In addition, the permeated albumin for the 
formulations of the second group were calculated 
as significant from those for the third group 
(p<0.05). Furthermore, the difference between 
permeated albumin after 1.5 and after 3 hours 
related to a certain formulation, was calculated as 
significant (p<0.05), for the formulations 5-6 and 
10-20, revealing more permeation after 3 hours 
than that after 1.5 hours.  
Moreover, similar significancies were existed for a 
certain enhancer (formulation) when used 2 mL 
and 4 mL (p<0.05), (except for DW and acetic acid 
solution), proving the positive effect of using 
higher concentrations of enhancers on the 
permeation.  
TABLE 1: CONSTITUENTS OF THE FORMULATIONS 1-6 (CONTAINING HYDROPHILIC SOLVENTS) AND 
QUANTITATIVE AMOUNTS OF THE CONSTITUENTS (mg or mL) 
Formulation 
number 
Albumin 
(500 mg) 
Solvent  Skin permeated albumin (mg) 
2 mL 4 mL After 1.5 hours After 3 hours 
1  DW ----- 5.2 5.2 
2  ----- DW 5.7 6.8 
3  Acetic acid (1 M) ----- 4.6 5.0 
4  ----- Acetic acid (1M) 4.7 5.8 
5  Ethyl acetate ----- 38.3 66.0 
6  ----- Ethyl acetate 46.6 69.0 
TABLE 2: CONSTITUENTS OF THE FORMULATIONS 7-20 (CONTAINING HYDROPHILIC POLYOL 
SOLVENTS) AND QUANTITATIVE AMOUNTS OF THE CONSTITUENTS (mg or mL) 
Formulation 
number 
Albumin 
(500 mg) 
Solvent Skin permeated albumin (mg) 
2 mL 4 mL After 1.5 hours After 3 hours 
7  Methanol ----- 6.5 6.5 
8  ----- Methanol 6.9 7.9 
9  Ethanol ----- 7.4 8.3 
10  ----- Ethanol 9.2 11.1 
11  2-propanol ----- 13.1 19.1 
12  ----- 2-propanol 20.5 25.2 
13  IPA ----- 20.5 24.0 
14  ----- IPA 26.4 32.0 
15  Glycerol ----- 47.9 75.6 
16  ----- Glycerol 67.0 98.0 
17  EG ----- 13.6 16.7 
18  ----- EG 14.3 21.3 
19  PG ----- 25.8 62.2 
20  ----- PG 39.0 74.3 
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Figure 1: Permeated albumin (mg) for formulations 1 and 
2 containing 2 and 4 mL of DW (no solvent), respectively.  
 
Figure 2: Permeated albumin (mg) for formulations 3 and 
4 containing 2 and 4 mL of acetic acid (1 M), respectively.  
 
Figure 3: Permeated albumin (mg) for formulations 5 and 
6 containing 2 and 4 mL of EA, respectively.  
 
Figure 4: Permeated albumin (mg) for formulations 7 and 
8 containing 2 and 4 mL of methanol, respectively. 
 
Figure 5. Permeated albumin (mg) for formulations 9 and 
10 containing 2 and 4 mL of ethanol, respectively. 
 
Figure 6. Permeated albumin (mg) for formulations 11 
and 12 containing 2 and 4 mL of 2-propanol, respectively. 
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Figure 7: Permeated albumin (mg) for formulations 13 
and 14 containing 2 and 4 mL of IPA, respectively. 
 
Figure 8: Permeated albumin (mg) for formulations 15 
and 16 containing 2 and 4 mL of glycerol, respectively. 
 
 
Figure 9: Permeated albumin (mg) for formulations 17 
and 18 containing 2 and 4 mL of EG, respectively. 
 
Figure 10: Permeated albumin (mg) for formulations 19 
and 20 containing 2 and 4 mL of PG, respectively. 
DISCUSSION: According to the results (and 
several existed literature), in the absence of 
enhancers, albumin did not considerably permeate 
the skin. That was due to its hydrophilicity and 
high molecular weight (67 kDa). Increase in water 
content (comparing formulations 1 and 2), did not 
change the albumin permeation. Using acetic acid 
(1M) instead of DW as a skin permeability 
enhancer, almost did not change the albumin 
permeation. 
Increase in the amount of acetic acid caused no 
more change in the permeation. Therefore, acetic 
acid (1M) was not recognized as an enhancer for 
albumin permeation. That was because of the fast 
evaporation of the acetic acid content and the low 
concentration of the acetic acid solution (1M) 
which could not be increased to avoid its harmful 
effects on skin. Methanol increased the permeation 
very slightly more than acetic acid (1M) and no 
difference was generated by increased amount of 
methanol. Ethanol showed albumin enhanced 
permeation even (slightly) more than that for 
methanol. Such effect was almost not higher for 
increased amount of ethanol. The reason of such 
slight effects is that methanol and ethanol can 
barely dissolve lipids of skin layers which are the 
main barrier for the penetration of albumin. 
Albumin permeation after 3 hours, approximately 
showed no difference from that after 1.5 hours, for 
formulations containing DW, acetic acid, methanol 
and ethanol, confirming the weak or absence of 
enhancing effect of these solvents. 
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2-propanol, IPA and EG each caused an 
enhancement of albumin permeation more than 
what caused by DW, acetic acid (1M), methanol or 
ethanol. Therefore, they were recognized as 
acceptable but weak enhancers for skin permeation 
of albumin. Among these three, the most enhancing 
effect was related to IPA, the moderate was related 
to 2-propanol and the least was related to EG. 
Although increase in amount of each of the three 
enhancers lead to an increase in albumin 
permeation (larger than those for DW, acetic acid 
(1M), methanol and ethanol), but such increase 
occurred mostly for IPA and then for 2-propanol in 
relation to EG.  
It means that IPA not only showed more enhancing 
effect but also presented more enhancing effect at a 
high concentration. In contrast to the above 
solvents (first group), increase in exposure time 
(from 1.5 to 3 hours), generated increased amount 
of permeated albumin for each of the IPA, 2-
propanol and EG. Such enhancing effect of these 
three enhancers is attributed to their weak to 
moderate ability for dissolving the skin lipids 
promoting the albumin permeation. That is why 
they could not make an outstanding permeation 
improvement. 
Using PG as enhancer, revealed a greater increased 
permeation compared to those for the previously 
mentioned formulations and decreased permeation 
compared to those related to EA and glycerol. 
Exceptionally PG showed a more permeation 
compared to that for EA when used as 4 mL and 
after 3 hours. Such a phenomenon made the EA a 
more rappid acting enhancer tha PG, although the 
maximum PG caused permeation was higher than 
that for EA. EA also lead to an incredibly high 
permeation, not only after 1.5 hours, but also a 
much more permeation after 3 hours like happened 
for PG. Increased amount of EA lead to a more 
permeation.  
Ultimately, the most permeation was occurred 
using glycerol which was introduced as the most 
effective enhancer with improved enhancement by 
increase in both exposure time and enhancer 
concentration. It also presented a higher speed of 
action compared to EA. The enhancing effect of 
EA, PG and glycerol are due to their powerful 
ability to dissolve skin lipids.  
In addition, PG and glycerol can absorb and retain 
water which strongly helped the permeation of 
albumin. Moreover, glycerol interact well with 
albumin leading to dissolve it in water content of 
the skin, concluding in a massive transfer of 
albumin across the skin layers. 
For the formulations containing 4 mLs of the 
enhancers, the permeated amounts of albumin were 
plotted for both exposure times, 1.5 hours (Figure 
11) and 3 hours (Figure 12). For most of the 
formulations (enhancers) the maximum permeation 
of albumin was occurred at 3 hours exposure time 
and when the enhancer was 4 mL (Figure 12). Thus 
Figure 12 presents a complete comparison between 
maximum permeations obtained for all 
formulations. As it is observed in figure 11, EA, 
PG and glycerol most effectively improved the 
permeation of albumin. The maximum permeated 
albumin was obtained using glycerol as enhancer (4 
mL) with exposure time of 3 hours, although still a 
huge amount of albumin (402 mg) did not permeate 
the skin. Comparing Figures 11 and 12, also 
demonstrates that despite the more total permeated 
albumin for PG compared to EA (Figure 12), EA 
possessed a significant more rapid enhancing action 
compared to PG (Figure 11). In case of speed of 
enhancing, again glycerol possessed the highest of 
all the enhancers.  
Although a few methods have been published for 
the transdermal delivery of albumin
24,25
, the 
method introduced in this study, i.e. using the 
enhancers, is an easier and less harmful way.  
 
Figure 11: Permeated albumin (mg) for formulations 2, 4, 8, 
10, 18, 12, 14, 6, 20 and 16, containing DW, acetic acid (1 
M), methanol, ethanol, EG, 2-propanol, IPA, EA, PG and 
glycerol, as enhancers, respectively, after 1.5 hours (n=3). 
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Figure 12: Permeated albumin (mg) for formulations 2, 4, 8, 
10, 18, 12, 14, 6, 20 and 16, containing DW, acetic acid (1 
M), methanol, ethanol, EG, 2-propanol, IPA, EA, PG and 
glycerol, as enhancers, respectively, after 3 hours (n=3). 
CONCLUSION: Among the hydrophilic solvents 
used in this study, Glycerol was found as the most 
potent enhancer for transdermal delivery of 
albumin and PG and EA were classified as the 
second order, while IPA, propanol and EG revealed 
weaker effects. Moreover, glycerol and EA could 
act more rapid than others. Such enhancers can 
effectively be used in topical products for 
improvement of skin permeation of albumin or 
other similar proteins. 
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